Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jeremy Levin
Biotech
Biotech leaders back FDA against ‘malicious’ abortion lawsuit
In the new amicus brief, the chief concern for the biotech industry is not mifepristone access per se, but the precedent the case could set.
Darren Incorvaia
Jul 22, 2026 9:00am
Ovid staff shuffle reads like a who's who of Big Pharma
Jul 9, 2021 9:50am
Ovid plans to shop with Takeda bucks after shedding lead asset
Apr 22, 2021 9:50am
Takeda brings an epilepsy med back into the fold
Mar 3, 2021 7:00am
Ovid flunks Angelman phase 3, leaving field wide open for rivals
Dec 2, 2020 7:56am
Takeda, Ovid plot next steps for rare epilepsy med
Sep 30, 2020 8:00am
